Takiron develops artificial bone:
This article was originally published in Clinica
Executive Summary
Takiron has developed an artificial bone material called Super-Fixsorb. The bioresorbable material is composed of bio- ceramic particles and poly-lactic acid. The biologically active material has a bending strength of 250-300 MPa and shearing strength of 110-150 MPa higher than cortical bone. Takiron, which is based in Osaka, Japan, says that Super-Fixsorb experiences minimal corrosion and prevents spongy bone formation because of the good strength match between the real and the artificial bone. The company plans to launch its product in 1998, reports Japan Medical Review.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.